927 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Acquired by Fiduciary Family Office LLC

Key Points

• Fiduciary Family Office LLC acquired a new stake in Thermo Fisher Scientific, purchasing 927 shares valued at approximately $461,000 during the first quarter.
• Several other institutional investors have also increased their positions in Thermo Fisher, with ownership by institutional investors and hedge funds now at 89.23% of the company's stock.
• Thermo Fisher Scientific reported earnings of $5.36 per share for the most recent quarter, exceeding analyst expectations, with revenue up 2.9% year-over-year at $10.86 billion.

Fiduciary Family Office LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 927 shares of the medical research company's stock, valued at approximately $461,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bernard Wealth Management Corp. purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $25,000. Ameriflex Group Inc. purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $30,000. IMA Advisory Services Inc. purchased a new stake in shares of Thermo Fisher Scientific in the 1st quarter valued at $35,000. Navigoe LLC purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $37,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in shares of Thermo Fisher Scientific in the 1st quarter valued at $37,000. Hedge funds and other institutional investors own 89.23% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on TMO shares. Barclays upped their price objective on shares of Thermo Fisher Scientific from $450.00 to $490.00 and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Wells Fargo & Company lowered their price target on shares of Thermo Fisher Scientific from $570.00 to $565.00 and set an "overweight" rating for the company in a report on Thursday, July 24th. Robert W. Baird upped their price target on shares of Thermo Fisher Scientific from $553.00 to $567.00 and gave the company an "outperform" rating in a report on Thursday, July 24th. The Goldman Sachs Group set a $610.00 price target on shares of Thermo Fisher Scientific and gave the company a "buy" rating in a report on Wednesday, April 23rd. Finally, Argus lowered their price target on shares of Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $593.00.

Thermo Fisher Scientific Stock Up 1.7%

Shares of Thermo Fisher Scientific stock traded up $8.31 during trading on Wednesday, hitting $485.72. The company's stock had a trading volume of 2,054,775 shares, compared to its average volume of 2,501,724. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.50 and a current ratio of 1.93. The company has a fifty day simple moving average of $429.68 and a two-hundred day simple moving average of $461.95. The company has a market capitalization of $183.41 billion, a PE ratio of 28.09, a P/E/G ratio of 2.47 and a beta of 0.74. Thermo Fisher Scientific Inc. has a 52 week low of $385.46 and a 52 week high of $627.88.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.22 by $0.14. The company had revenue of $10.86 billion during the quarter, compared to analyst estimates of $10.68 billion. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. Thermo Fisher Scientific's quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the business earned $5.37 EPS. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.

Thermo Fisher Scientific Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.95%.

Insider Transactions at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 400 shares of the firm's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $479.98, for a total transaction of $191,992.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares in the company, valued at approximately $10,735,712.66. This trade represents a 1.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 8,000 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $454.45, for a total transaction of $3,635,600.00. Following the sale, the chief executive officer owned 115,174 shares of the company's stock, valued at approximately $52,340,824.30. This represents a 6.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 18,400 shares of company stock valued at $8,345,792. 0.33% of the stock is owned by company insiders.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.